Transcelerate Biopharma starts newco to explore preclinical toxicology data
Transcelerate Biopharma Inc., a nonprofit established by 10 of the industry's largest pharmas in 2012, is launching Biocelerate, a new subsidiary that aims to improve efficiencies in preclinical research, first by working to illuminate the relationship between patient response and preclinical toxicology findings.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST